Clinical Trials Directory

Trials / Conditions / Stage IV Prostate Adenocarcinoma

Stage IV Prostate Adenocarcinoma

6 registered clinical trials studyying Stage IV Prostate Adenocarcinoma.

StatusTrialSponsorPhase
TerminatedCabazitaxel and Prednisone in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer
NCT02844582
University of California, DavisPhase 2
CompletedPhase IB Trial of Radium-223 and Niraparib in Patients With Castrate Resistant Prostate Cancer (NiraRad)
NCT03076203
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson UniversityPhase 1
Completed68Ga-RM2 PET/CT in Detecting Regional Nodal and Distant Metastases in Patients With Intermediate or High-Risk
NCT03113617
Andrei IagaruPhase 2
CompletedBiomarker-Driven Therapy With Nivolumab and Ipilimumab in Treating Patients With Metastatic Hormone-Resistant
NCT02601014
Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsPhase 2
CompletedNiclosamide and Enzalutamide in Treating Patients With Castration-Resistant, Metastatic Prostate Cancer
NCT02532114
University of WashingtonPhase 1
CompletedAbiraterone Acetate in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer
NCT01503229
University of WashingtonPhase 2